KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $2.49.

  • Cme's EPS (Weighted Average and Diluted) fell 40.0% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.32, marking a year-over-year increase of 851.74%. This contributed to the annual value of $9.67 for FY2024, which is 915.39% up from last year.
  • According to the latest figures from Q3 2025, Cme's EPS (Weighted Average and Diluted) is $2.49, which was down 40.0% from $2.81 recorded in Q2 2025.
  • Over the past 5 years, Cme's EPS (Weighted Average and Diluted) peaked at $2.81 during Q2 2025, and registered a low of $1.42 during Q2 2021.
  • In the last 5 years, Cme's EPS (Weighted Average and Diluted) had a median value of $2.24 in 2023 and averaged $2.17.
  • As far as peak fluctuations go, Cme's EPS (Weighted Average and Diluted) soared by 12434.78% in 2021, and later crashed by 2751.94% in 2022.
  • Quarter analysis of 5 years shows Cme's EPS (Weighted Average and Diluted) stood at $1.69 in 2021, then increased by 4.14% to $1.76 in 2022, then grew by 27.12% to $2.24 in 2023, then increased by 7.25% to $2.4 in 2024, then increased by 3.77% to $2.49 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $2.49 for Q3 2025, versus $2.81 for Q2 2025 and $2.62 for Q1 2025.